Arik Zucker

Showing 1-2 of 2 articles

Author Pannipa Suwannasom

Coronary interventions

First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis

Suwannasom P, Sotomi Y, Corti R, Kurz D, Roffi M, von Birgelen C, Buzzi S, Zucker A, Dijkstra J, Wykrzykowska J, de Winter R, Windecker S, Onuma Y, Serruys P, Daemen J, Räber L

April 20, 2017 | 10.4244/EIJ-D-16-00975

Author Kumaran Kolandaivelu

Coronary interventions

Ultra-hydrophilic stent platforms promote early vascular healing and minimise late tissue response: a potential alternative to second-generation drug-eluting stents

Kolandaivelu K, Bailey L, Buzzi S, Zucker A, Milleret V, Ziogas A, Ehrbar M, Khattab A, Stanley J, Wong G, Zani B, Markham P, Tzafriri A, Bhatt D, Edelman E

April 20, 2017 | 10.4244/EIJ-D-15-00497

1

Latest news

Discover the Special Edition on valvular heart disease prepared for PCR London Valves

(3D-TEE model - Optimal implantation)

November 15, 2019

2019 – A leap year for valvular heart disease

(Course directors PCR London Valves 2019)

November 15, 2019

This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more

December 3, 2019

New update! Discover 17 new trials

(The Trials book is supported by Biotronik)

October 29, 2019

Guidance Papers

Guidelines, consensus & position papers

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Last week's JAA's: DYNAMIC Trial, S3U registry and much more

November 26, 2019

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke